25 GG 331 (Levothyroxine 25 mcg (0.025 mg))

Pill imprint 25 GG 331 has been identified as Levothyroxine sodium 25 mcg (0.025 mg).

Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 25 GG 331

Levothyroxine sodium 25 mcg (0.025 mg) 25 GG 331
Levothyroxine sodium
Imprint:
25
GG 331
Strength:
25 mcg (0.025 mg)
Color:
Orange
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5180
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55887-0503 Diversified Healthcare Services Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)